286 related articles for article (PubMed ID: 30403262)
1. Evaluation of toxic retinopathy caused by antimalarial medications with spectral domain optical coherence tomography.
Cabral RTS; Klumb EM; Couto MINN; Carneiro S
Arq Bras Oftalmol; 2019; 82(1):12-17. PubMed ID: 30403262
[TBL] [Abstract][Full Text] [Related]
2. [Antimalarial drug retinopathy].
Guiot A; Couturier M; Tebib JG; Abouaf L; Coury F
Rev Med Interne; 2018 May; 39(5):364-368. PubMed ID: 29496271
[TBL] [Abstract][Full Text] [Related]
3. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
Michaelides M; Stover NB; Francis PJ; Weleber RG
Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
[TBL] [Abstract][Full Text] [Related]
4. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hydroxychloroquine retinopathy with long-term use in a cohort of Indian patients with rheumatic diseases.
Manoj M; Sahoo RR; Singh A; Hazarika K; Bafna P; Kaur A; Wakhlu A
Rheumatol Int; 2021 May; 41(5):929-937. PubMed ID: 33704526
[TBL] [Abstract][Full Text] [Related]
6. [Severe chloroquine- and hydroxychloroquine-induced retinopathy].
Ingster-Moati I; Bui Quoc E; Crochet M; Orssaud C; Dufier JL; Roche O
J Fr Ophtalmol; 2006 Jun; 29(6):642-50. PubMed ID: 16885894
[TBL] [Abstract][Full Text] [Related]
7. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
Ahn SJ; Joung J; Lee BR
Am J Ophthalmol; 2019 Mar; 199():71-81. PubMed ID: 30448463
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
Aylward JM
J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiological and SD-OCT findings in patients receiving chloroquine therapy in relation to cumulative dosage and duration of treatment.
Bertoli F; Šuštar M; Jarc Vidmar M; Perovšek D; Brecelj J; Markelj Š; Jaki Mekjavić P; Šuput D; Tomšič M; Isola M; Battistella C; Lanzetta P; Hawlina M
Doc Ophthalmol; 2020 Aug; 141(1):1-14. PubMed ID: 31927702
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic methods for chloroquine diphosphate induced retinopathy in systemic lupus erythematosus].
Rodrigues LD; Shinjo SK; Oyamada MK; Serracarbassa PD; Takahashi WY; Borba EF; Bonfá ES; Nakashima Y
Arq Bras Oftalmol; 2009; 72(3):313-20. PubMed ID: 19668959
[TBL] [Abstract][Full Text] [Related]
11. Screening for toxic retinopathy due to antimalarial drugs in Tunisia.
Zone-Abid I; Maaloul K; Halouani S; Frikha F; Marzouk S; Bahloul Z; Trigui A
J Fr Ophtalmol; 2023 Apr; 46(4):356-362. PubMed ID: 36759246
[TBL] [Abstract][Full Text] [Related]
12. Spectral-domain optical coherence tomography as a screening technique for chloroquine and hydroxychloroquine retinal toxicity.
Kahn JB; Haberman ID; Reddy S
Ophthalmic Surg Lasers Imaging; 2011; 42(6):493-7. PubMed ID: 21830746
[TBL] [Abstract][Full Text] [Related]
13. Retinal toxicity due to antimalarials: frequency and risk factors.
Palma Sánchez D; Rubio Velazquez E; Soro Marín S; Reyes García R
Reumatol Clin; 2013; 9(5):259-62. PubMed ID: 23707434
[TBL] [Abstract][Full Text] [Related]
14. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.
Rodriguez-Padilla JA; Hedges TR; Monson B; Srinivasan V; Wojtkowski M; Reichel E; Duker JS; Schuman JS; Fujimoto JG
Arch Ophthalmol; 2007 Jun; 125(6):775-80. PubMed ID: 17562988
[TBL] [Abstract][Full Text] [Related]
15. Case Report: Hydroxychloroquine Retinopathy.
Eldeeb M; Chan EW; Omar A
Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
[TBL] [Abstract][Full Text] [Related]
16. [SD-OCT As screening test for hydroxychloroquine retinopathy: The «flying saucer» sign].
Asensio-Sánchez VM
Arch Soc Esp Oftalmol; 2015 Jul; 90(7):338-40. PubMed ID: 25443193
[TBL] [Abstract][Full Text] [Related]
17. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
Mavrikakis I; Sfikakis PP; Mavrikakis E; Rougas K; Nikolaou A; Kostopoulos C; Mavrikakis M
Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
[TBL] [Abstract][Full Text] [Related]
18. [The ERG contribution in early diagnosis of chloroquine and hydroxychloroquine maculopathy].
Karkanová M; Matusková V; Vlková E; Dosková H; Uhmannová R
Cesk Slov Oftalmol; 2010 Apr; 66(2):62-6. PubMed ID: 20925239
[TBL] [Abstract][Full Text] [Related]
19. [Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses].
Rüther K; Foerster J; Berndt S; Schroeter J
Ophthalmologe; 2007 Oct; 104(10):875-9. PubMed ID: 17653725
[TBL] [Abstract][Full Text] [Related]
20. Progression of hydroxychloroquine retinopathy after discontinuation of therapy: case report.
Wei LC; Chen SN; Ho CL; Kuo YH; Ho JD
Chang Gung Med J; 2001 May; 24(5):329-34. PubMed ID: 11480331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
